Connection

Bryan Toole to Antineoplastic Agents

This is a "connection" page, showing publications Bryan Toole has written about Antineoplastic Agents.
Connection Strength

0.325
  1. Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol. 2008 Aug; 9(4):249-52.
    View in: PubMed
    Score: 0.182
  2. Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma. Leukemia. 2011 Oct; 25(10):1598-609.
    View in: PubMed
    Score: 0.055
  3. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat. 2008 Jun; 11(3):110-21.
    View in: PubMed
    Score: 0.045
  4. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem. 2003 Jul 11; 278(28):25285-8.
    View in: PubMed
    Score: 0.032
  5. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Clin Cancer Res. 2008 Mar 15; 14(6):1804-13.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.